Daniel Anderson is a Respiratory physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1771 Tate Blvd SE
Ste 103
Hickory, NC 28602
Telephone
828-322-1128Provider last certified this registry record 23 May 2023.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Insmed, Inc.Program year20242 payments
- AstraZeneca Pharmaceuticals LPProgram year20232 payments
- Actelion Pharmaceuticals US, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
74.1%Corticosteroid46.3%Trelegy Ellipta40%Breztri Aerosphere24%Symbicort10%Budesonide-Formoterol Fumarate8%Fluticasone Propionate8%Breo Ellipta7%Breyna4%Part D<11 patientsbeta2-Adrenergic Agonist18.3%Albuterol Sulfate Hfa79%Ventolin Hfa21%Part D≥87 patients+ 4 more classes in this area
Metabolism & gastrointestinal
13.4%Corticosteroid9%Prednisone100%Part D≥79 patientsProton pump inhibitor4.4%Pantoprazole Sodium53%Omeprazole47%Part D<11 patientsAnti-infectives
10.9%Macrolide Antimicrobial7.4%Azithromycin100%Part D≥70 patientsTetracycline-class Drug2.4%Doxycycline Hyclate100%Part D≥36 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”